Bladder Cancer
Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC.
March 19, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.
March 18, 2024
Characterization of Targets for Antibody-Drug Conjugates in Advanced Urothelial Carcinoma - Expert Commentary
March 15, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
March 14, 2024
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
March 14, 2024
Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
March 14, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.
March 13, 2024
Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with Intravesical BCG vs Immediate Radical Cystectomy.
March 13, 2024
Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma.
March 12, 2024